PRevention Using EPA Against coloREctal Cancer
Condition: Colorectal Adenoma Intervention: Drug: AMR101 (VASCEPA, icosapent ethyl) Sponsors: Harvard Medical School; Harvard School of Public Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials